An ongoing securities fraud investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) continues, following a whistleblower lawsuit that alleges financial manipulation. The lawsuit, filed under the SEC's whistleblower program, claims that the company engaged in improper revenue recognition practices to inflate its financial results.
According to the whistleblower complaint, Alignment Healthcare allegedly manipulated its Medicare Advantage risk adjustment data to boost revenue, which would have misled investors about the company's true financial health. The company has denied the allegations, stating that it believes the claims are without merit and that it is cooperating with regulators.
The investigation is being conducted by the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ). As of August 1, 2026, no formal charges have been filed against the company, and the investigation remains in its early stages.
Investors are advised to monitor the situation closely, as the outcome of the investigation could have significant implications for the company's stock price and future operations. Alignment Healthcare, a healthcare services company focused on Medicare Advantage plans, has seen its stock price fluctuate amid the news.
